pad

ASCO 2002

pad
padTech Assess:Aromatase Inhib (Adjuvant)
pad
Status Report (advocates participated in this panel)
pad
pad
padFDA Presents: Tamoxifen & Uterine Sarcoma
pad
Cancer Information Service Reports on ASCO 2002 presentation
pad
Uterine Sarcoma Risk
Advocate Letter to FDA on Warning Labels, 2002
Risk Maliganant Mixed Mullerian Tumors *(Uterine)
pad
pad
padSurvival/QOL: Advanced Pancreatic Ca
pad
Abstract #2359
pad
pad
pad9-cis retin acid vs 13-cis+alpha-tocoph vs placebo
pad
Abstract #1177 (excerpted)
pad
pad
pad
padPts Who Smoke w/ Chemo/Rads
pad
#1176 (excerpts)
pad
pad
padZolendronic Acid & Mets from Solid Tumors
pad
#1179 (excerpts)
pad
pad
pad
padUse of CAM in Phase I Clinical Trials
pad
#1028
pad
pad
padPregnancy :Lymphoma Pt Not Adverse Prognosis
pad
Abstract #1141
pad
pad
pad
padUnwanted Results:Failure to Publish
pad
#973
pad
pad
padOperational Bias in Assessing Time to Progression (TTP)
pad
#975
pad
pad

Remember we are NOT Doctors and have NO medical training.

This site is like an Encylopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.